Evidence map›Paper›PMID 42315833›Full record

ArticleNature communications2026

A functional map of phosphoprotein phosphatase regulation identifies an evolutionarily conserved reductase for the catalytic metal ions.

Bob Meeusen, Sara M Ambjørn, Jiri Veis, Rachel C Riley, Gianmatteo Vit, Brooke L Brauer, Mads H Møller, Elora C Greiner, Camilla B Chan, Anna M Schmoker and 8 more

Abstract read
In one paragraph

Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

18 authors.

Bob Meeusen *Center for Epigenetic Cell Memory, Danish Cancer Institute, Copenhagen, Denmark.
Sara M Ambjørn *Center for Epigenetic Cell Memory, Danish Cancer Institute, Copenhagen, Denmark.ORCID 0000-0002-5571-1382
Jiri VeisMax Perutz Labs, Vienna BioCenter, Vienna, Austria.
Rachel C RileyDepartment of Biochemistry and Cell Biology, Dartmouth Geisel School of Medicine, Hanover, NH, USA.
Gianmatteo VitNovo Nordisk Foundation Center for Protein Research, ICMM, University of Copenhagen, Copenhagen, Denmark.
Brooke L BrauerDepartment of Biochemistry and Cell Biology, Dartmouth Geisel School of Medicine, Hanover, NH, USA.
Mads H MøllerNovo Nordisk Foundation Center for Protein Research, ICMM, University of Copenhagen, Copenhagen, Denmark.ORCID 0009-0004-0318-7058
Elora C GreinerDepartment of Biochemistry and Cell Biology, Dartmouth Geisel School of Medicine, Hanover, NH, USA.
Camilla B ChanCenter for Epigenetic Cell Memory, Danish Cancer Institute, Copenhagen, Denmark.
Anna M SchmokerDartmouth Cancer Center, Lebanon, NH, USA.ORCID 0000-0003-2830-5650
Blanca Lopez MendezNovo Nordisk Foundation Center for Protein Research, ICMM, University of Copenhagen, Copenhagen, Denmark.ORCID 0000-0001-8541-4904
Melanie B WeisserNovo Nordisk Foundation Center for Protein Research, ICMM, University of Copenhagen, Copenhagen, Denmark.ORCID 0000-0003-3946-3929
Dimitriya H GarvanskaCenter for Epigenetic Cell Memory, Danish Cancer Institute, Copenhagen, Denmark.
Hao ZhuUniversity of Kansas Medical Center, Kansas City, KS, USA.ORCID 0000-0003-0866-9246
Norman E DaveyInstitute of Cancer Research, London, UK.ORCID 0000-0001-6988-4850
Arminja N KettenbachDepartment of Biochemistry and Cell Biology, Dartmouth Geisel School of Medicine, Hanover, NH, USA. Arminja.N.Kettenbach@dartmouth.edu.ORCID 0000-0003-3979-4576
Egon OgrisMax Perutz Labs, Vienna BioCenter, Vienna, Austria. egon.ogris@meduniwien.ac.at.ORCID 0000-0001-5950-9264
Jakob NilssonCenter for Epigenetic Cell Memory, Danish Cancer Institute, Copenhagen, Denmark. jaknil@cancer.dk.ORCID 0000-0003-4100-1125

Funding

Translational Engineering in Cancer (TEC)P30CA023108 · NCI · DARTMOUTH COLLEGE · PI Fred W Kolling IV · 1985 to 2026
$91.3M
University of Kansas Alzheimer's Disease Research Center (KU ADRC)P30AG072973 · NIA · UNIVERSITY OF KANSAS MEDICAL CENTER · PI Mohammad Haeri · 2021 to 2026
$25.3M
Phosphorylation Signaling by Phosphoprotein PhosphatasesR35GM119455 · NIGMS · DARTMOUTH COLLEGE · PI Arminja Nadine Kettenbach · 2016 to 2026
$5.1M
NCI NIH HHS P30 CA023108NIA NIH HHS P30 AG072973NIGMS NIH HHS R35 GM119455Novo Nordisk Fonden (Novo Nordisk Foundation) NNF14CC0001
6 · The paper itself

Abstract

Serine/threonine phosphoprotein phosphatases (PPPs) are conserved metalloenzymes and key regulators of intracellular signaling. Here, we systematically map the components and residues required for PP2A-like phosphatase (PP2A/PP4/PP6) function using genome-wide CRISPR knockout and focused base editing screens and provide this as a comprehensive resource. We uncover the reductase CYB5R4 as an evolutionarily conserved activator of PP4 and PP6, but not PP2A. We demonstrate that PP4 and PP6 are redox sensitive and require CYB5R4 to reduce the active site metal ions for activation. Mechanistically, this involves the selective binding of PP4 and PP6 through binding elements in the N-terminal tail of CYB5R4 and CYB5R4-bound heme serving as an electron donor for the active site. We further show that this activation is critical for regulating the response to DNA damage. Our work hints that active site metal ion redox regulation mediates crosstalk between the oxidative state of the cell and specific phosphatase activities.

Indexed as

MetalsOxidoreductasesPhosphoprotein PhosphatasesCatalytic DomainDNA DamageEvolution, MolecularHumansOxidation-ReductionMetalsOxidoreductasesPhosphoprotein Phosphatasesprotein phosphatase 4

Identifiers

PMID42315833
PMCPMC13434041

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.